Menu

rss

Register now to receive the Table of Contents and other relevant alerts by email each issue

October 2003, Volume 52, Issue 10

[Author index]

Cover
  1. Commentaries
  2. Digest
  3. Oesophagus
  4. Stomach
  5. Small intestine
  6. Inflammation and inflammatory bowel disease
  7. Colon
  8. Pancreas
  9. Liver
  10. Case report
  11. Review
  12. Letters
[Search ALL Issues]

View multiple abstracts by picking relevant boxes and click Get all checked abstracts

Issue information

[Front cover]

Commentaries

  • Nutritional therapy for cancer cachexia

    • R F Grimble
    Gut 2003;52:10 1391-1392 doi:10.1136/gut.52.10.1391

  • Origins of cardiac dysfunction in cirrhosis

    • W Jiménez,
    • V Arroyo
    Gut 2003;52:10 1392-1394 doi:10.1136/gut.52.10.1392

  • Transplanting the genetic susceptibility to Crohn’s disease

    • M H Holtmann,
    • M F Neurath
    Gut 2003;52:10 1394-1396 doi:10.1136/gut.52.10.1394

Digest

  • Digest

    • Robin Spiller
    Gut 2003;52:10 1391 doi:10.1136/gut.52.10.1391-a

Oesophagus

  • Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors

    • G H Koek,
    • D Sifrim,
    • T Lerut,
    • J Janssens,
    • J Tack
    Gut 2003;52:10 1397-1402 doi:10.1136/gut.52.10.1397

Stomach

  • Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial

    • P W Y Chiu,
    • C Y W Lam,
    • S W Lee,
    • K H Kwong,
    • S H Lam,
    • D T Y Lee,
    • S P Y Kwok
    Gut 2003;52:10 1403-1407 doi:10.1136/gut.52.10.1403

  • Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner

    • J R Bebb,
    • D P Letley,
    • R J Thomas,
    • F Aviles,
    • H M Collins,
    • S A Watson,
    • N M Hand,
    • A Zaitoun,
    • J C Atherton
    Gut 2003;52:10 1408-1413 doi:10.1136/gut.52.10.1408

  • Role of cognitive factors in symptom induction following high and low fat meals in patients with functional dyspepsia

    • C Feinle-Bisset,
    • B Meier,
    • M Fried
    Gut 2003;52:10 1414-1418 doi:10.1136/gut.52.10.1414

Small intestine

  • Efficacy and tolerability of racecadotril in the treatment of cholera in adults: a double blind, randomised, controlled clinical trial

    • N H Alam,
    • H Ashraf,
    • W A Khan,
    • M M Karim,
    • G J Fuchs
    Gut 2003;52:10 1419-1423 doi:10.1136/gut.52.10.1419

  • Scavenger receptor class B type I (SR-BI) in pig enterocytes: trafficking from the brush border to lipid droplets during fat absorption

    • G H Hansen,
    • L-L Niels-Christiansen,
    • L Immerdal,
    • E M Danielsen
    Gut 2003;52:10 1424-1431 doi:10.1136/gut.52.10.1424

Inflammation and inflammatory bowel disease

  • Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001

    • H Hildebrand,
    • Y Finkel,
    • L Grahnquist,
    • J Lindholm,
    • A Ekbom,
    • J Askling
    Gut 2003;52:10 1432-1434 doi:10.1136/gut.52.10.1432

  • Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

    • S Danese,
    • J A Katz,
    • S Saibeni,
    • A Papa,
    • A Gasbarrini,
    • M Vecchi,
    • C Fiocchi
    Gut 2003;52:10 1435-1441 doi:10.1136/gut.52.10.1435

  • Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts

    • L E M Willemsen,
    • M A Koetsier,
    • S J H van Deventer,
    • E A F van Tol
    Gut 2003;52:10 1442-1447 doi:10.1136/gut.52.10.1442

  • Inducible CD40 expression mediates NFκB activation and cytokine secretion in human colonic fibroblasts

    • C M Gelbmann,
    • S N Leeb,
    • D Vogl,
    • M Maendel,
    • H Herfarth,
    • J Schölmerich,
    • W Falk,
    • G Rogler
    Gut 2003;52:10 1448-1456 doi:10.1136/gut.52.10.1448

  • Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse

    • G Barbara,
    • R De Giorgio,
    • V Stanghellini,
    • R Corinaldesi,
    • C Cremon,
    • N Gerard,
    • C Gerard,
    • E F Grady,
    • N W Bunnett,
    • P A Blennerhassett,
    • S M Collins
    Gut 2003;52:10 1457-1464 doi:10.1136/gut.52.10.1457

Colon

  • The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development

    • C Bonhomme,
    • I Duluc,
    • E Martin,
    • K Chawengsaksophak,
    • M-P Chenard,
    • M Kedinger,
    • F Beck,
    • J-N Freund,
    • C Domon-Dell
    Gut 2003;52:10 1465-1471 doi:10.1136/gut.52.10.1465

  • Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells

    • H Sheng,
    • J Shao,
    • C M Townsend, jr,
    • B M Evers
    Gut 2003;52:10 1472-1478 doi:10.1136/gut.52.10.1472

  • Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

    • K C H Fearon,
    • M F von Meyenfeldt,
    • A G W Moses,
    • R van Geenen,
    • A Roy,
    • D J Gouma,
    • A Giacosa,
    • A Van Gossum,
    • J Bauer,
    • M D Barber,
    • N K Aaronson,
    • A C Voss,
    • M J Tisdale
    Gut 2003;52:10 1479-1486 doi:10.1136/gut.52.10.1479

Pancreas

  • Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis

    • N Ohnishi,
    • T Miyata,
    • H Ohnishi,
    • H Yasuda,
    • K Tamada,
    • N Ueda,
    • H Mashima,
    • K Sugano
    Gut 2003;52:10 1487-1493 doi:10.1136/gut.52.10.1487

Liver

  • Mutations in SRD5B1 (AKR1D1), the gene encoding Δ4-3-oxosteroid 5β-reductase, in hepatitis and liver failure in infancy

    • H A Lemonde,
    • E J Custard,
    • J Bouquet,
    • M Duran,
    • H Overmars,
    • P J Scambler,
    • P T Clayton
    Gut 2003;52:10 1494-1499 doi:10.1136/gut.52.10.1494

  • Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy

    • C Skipper,
    • J M Guy,
    • J Parkes,
    • P Roderick,
    • W M Rosenberg
    Gut 2003;52:10 1500-1504 doi:10.1136/gut.52.10.1500

  • Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation

    • R B Vaughan,
    • P W Angus,
    • J P F Chin-Dusting
    Gut 2003;52:10 1505-1510 doi:10.1136/gut.52.10.1505

  • Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease

    • J H Henriksen,
    • J P Gøtze,
    • S Fuglsang,
    • E Christensen,
    • F Bendtsen,
    • S Møller
    Gut 2003;52:10 1511-1517 doi:10.1136/gut.52.10.1511

Case report

  • Fulminant Crohn’s colitis after allogeneic stem cell transplantation

    • S A Sonwalkar,
    • R M James,
    • T Ahmad,
    • L Zhang,
    • C S Verbeke,
    • D L Barnard,
    • D P Jewell,
    • M A Hull
    Gut 2003;52:10 1518-1521 doi:10.1136/gut.52.10.1518

Review

  • The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria

    • A J Stagg,
    • A L Hart,
    • S C Knight,
    • M A Kamm
    Gut 2003;52:10 1522-1529 doi:10.1136/gut.52.10.1522

Letters

  • Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

    • R F Logan,
    • T P van Staa
    1. Commentator:
      • M J S Langman and
      • R A J Ransford
    Gut 2003;52:10 1530-1531 doi:10.1136/gut.52.10.1530

  • Worsening of steatosis and fibrosis progression in hepatitis C

    • L Castéra,
    • J-M Pawlotsky,
    • D Dhumeaux
    Gut 2003;52:10 1531 doi:10.1136/gut.52.10.1531

  • Complete regression of advanced HCC with long acting octreotide

    • J T Siveke,
    • C Folwaczny,
    • C Herberhold
    Gut 2003;52:10 1531 doi:10.1136/gut.52.10.1531-a

  • Diagnosing small bowel Crohn’s disease with wireless capsule endoscopy

    • K Schulmann,
    • S Hollerbach,
    • W Schmiegel
    1. Commentator:
      • Z Fireman and
      • Y Kopelman
    Gut 2003;52:10 1531-1532 doi:10.1136/gut.52.10.1531-b

  • Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C

    • T Poynard
    Gut 2003;52:10 1532 doi:10.1136/gut.52.10.1532

  • Risk of fracture in coeliac disease

    • R Logan,
    • J West
    Gut 2003;52:10 1532 doi:10.1136/gut.52.10.1532-a

View multiple abstracts by picking relevant boxes and click Get all checked abstracts

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Gut.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.